choline has been researched along with Cholera Infantum in 13 studies
Excerpt | Relevance | Reference |
---|---|---|
"The safety and efficacy of a novel combination treatment of AChE inhibitors and choline supplement was initiated and evaluated in children and adolescents with autism spectrum disorder (ASD)." | 9.30 | Improvement of Language in Children with Autism with Combined Donepezil and Choline Treatment. ( Ben-Hur, R; Gabis, LV; Jokel, A; Shalom, DB; Shefer, S, 2019) |
"Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease, and its pathological development is closely related to the gut-liver axis." | 5.91 | Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction. ( Chen, R; Dong, H; Fan, W; Guo, C; Guo, L; Li, Q; Qu, X; Wang, X; Zhang, X; Zhang, Y, 2023) |
"Choline is an essential nutrient, and its deficiency causes steatohepatitis." | 5.91 | Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis. ( Abukawa, D; Ando, T; Azuma, Y; Fukuda, A; Hayashi, H; Inui, A; Kaji, S; Kasahara, M; Kusuhara, H; Mizuno, S; Mizuno, T; Nakano, S; Okamoto, T; Sabu, Y; Sakamoto, S; Shimizu, S; Suzuki, M; Takahashi, S; Tamura, R; Zen, Y, 2023) |
"The safety and efficacy of a novel combination treatment of AChE inhibitors and choline supplement was initiated and evaluated in children and adolescents with autism spectrum disorder (ASD)." | 5.30 | Improvement of Language in Children with Autism with Combined Donepezil and Choline Treatment. ( Ben-Hur, R; Gabis, LV; Jokel, A; Shalom, DB; Shefer, S, 2019) |
"Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease, and its pathological development is closely related to the gut-liver axis." | 1.91 | Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction. ( Chen, R; Dong, H; Fan, W; Guo, C; Guo, L; Li, Q; Qu, X; Wang, X; Zhang, X; Zhang, Y, 2023) |
"Choline is an essential nutrient, and its deficiency causes steatohepatitis." | 1.91 | Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis. ( Abukawa, D; Ando, T; Azuma, Y; Fukuda, A; Hayashi, H; Inui, A; Kaji, S; Kasahara, M; Kusuhara, H; Mizuno, S; Mizuno, T; Nakano, S; Okamoto, T; Sabu, Y; Sakamoto, S; Shimizu, S; Suzuki, M; Takahashi, S; Tamura, R; Zen, Y, 2023) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (76.92) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (7.69) | 24.3611 |
2020's | 2 (15.38) | 2.80 |
Authors | Studies |
---|---|
Guo, C | 1 |
Li, Q | 1 |
Chen, R | 1 |
Fan, W | 1 |
Zhang, X | 1 |
Zhang, Y | 1 |
Guo, L | 1 |
Wang, X | 1 |
Qu, X | 1 |
Dong, H | 1 |
Tamura, R | 1 |
Sabu, Y | 1 |
Mizuno, T | 1 |
Mizuno, S | 1 |
Nakano, S | 1 |
Suzuki, M | 1 |
Abukawa, D | 1 |
Kaji, S | 1 |
Azuma, Y | 1 |
Inui, A | 1 |
Okamoto, T | 1 |
Shimizu, S | 1 |
Fukuda, A | 1 |
Sakamoto, S | 1 |
Kasahara, M | 1 |
Takahashi, S | 1 |
Kusuhara, H | 1 |
Zen, Y | 1 |
Ando, T | 1 |
Hayashi, H | 1 |
Gabis, LV | 1 |
Ben-Hur, R | 1 |
Shefer, S | 1 |
Jokel, A | 1 |
Shalom, DB | 1 |
HANDLER, P | 1 |
FOLLIS, RH | 1 |
EISELE, CW | 1 |
McCULLOUGH, NB | 1 |
SCHOENTAL, R | 1 |
HEAD, MA | 1 |
BUZZONI, G | 1 |
CIVOLANI, L | 1 |
TUSCH, E | 1 |
de la HUERGA, J | 1 |
POPPER, H | 1 |
GRIMSON, KS | 1 |
Heitkamp, K | 1 |
Busch-Stockfisch, M | 1 |
Heide, M | 1 |
Rocca, F | 1 |
1 review available for choline and Cholera Infantum
Article | Year |
---|---|
[The pros and cons of honey--are statements about the effects of honey "scientifically verified"?].
Topics: Acetylcholine; Amino Acids; Amylases; beta-Fructofuranosidase; Choline; Diabetes Mellitus; Enzymes; | 1986 |
1 trial available for choline and Cholera Infantum
Article | Year |
---|---|
Improvement of Language in Children with Autism with Combined Donepezil and Choline Treatment.
Topics: Adolescent; Autistic Disorder; Child; Choline; Donepezil; Drug Therapy, Combination; Female; Gastroi | 2019 |
11 other studies available for choline and Cholera Infantum
Article | Year |
---|---|
Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction.
Topics: Animals; Choline; Flavanones; Gastrointestinal Diseases; Intestinal Diseases; Liver; Methionine; Mic | 2023 |
Intestinal Atp8b1 dysfunction causes hepatic choline deficiency and steatohepatitis.
Topics: Adenosine Triphosphatases; Animals; Child; Choline; Choline Deficiency; Fatty Liver; Female; Gastroi | 2023 |
The role of thyroid activity in the pathogenesis of hepatic lesions due to choline and cystine deficiency.
Topics: Choline; Choline Deficiency; Cysteine; Cystine; Gastrointestinal Diseases; Liver; Liver Diseases; Th | 1948 |
An evaluation of laboratory tests of use in the diagnosis of brucellosis.
Topics: Brucellosis; Choline; Disease; Gastrointestinal Diseases; Gastrointestinal Tract; Humans | 1948 |
Progression of liver lesions produced in rats by temporary treatment with pyrrolizidine (senecio) alkaloids, and the effects of betaine and high casein diet.
Topics: Animals; Betaine; Caseins; Choline; Diet; Disease Progression; Gastrointestinal Diseases; Liver Neop | 1957 |
[ON THE THERAPEUTIC ACTION OF CHOLINE PANTOTHENATE].
Topics: Biliary Tract; Choline; Gastrointestinal Diseases; Humans; Pantothenic Acid | 1965 |
[Lipotropic substances in the treatment of liver lesions].
Topics: Choline; Gastrointestinal Diseases; Lipotropic Agents; Liver Diseases | 1954 |
Urinary excretion of choline metabolites following choline administration in normals and patients with hepatobiliary diseases.
Topics: Biliary Tract; Chemical and Drug Induced Liver Injury; Choline; Gastrointestinal Diseases; Humans; L | 1951 |
Cholinergic and anticholinergic drugs and their trial in treatment of gastrointestinal disorders; trial of urecholine and banthine.
Topics: Autonomic Nervous System; Bethanechol Compounds; Choline; Cholinergic Agents; Cholinergic Antagonist | 1950 |
[The treatment of gastrointestinal disorders with Enzymed].
Topics: Amylases; Ascorbic Acid; Choline; Delayed-Action Preparations; Enzyme Therapy; Folic Acid; Gastroint | 1968 |
[Clinical experience with a new hepatoprotector].
Topics: Adolescent; Adult; Bilirubin; Choline; Gastrointestinal Diseases; Hepatitis; Homocysteine; Humans; L | 1969 |